Participate in Share Chat. Set up virtual watchlists and portfolios See more trades and share info.
Register for FREE Now
Tiziana Life Sciences has been granted an exclusive license to develop and commercialise Novimmune SA's CD3 receptor monoclonal antibody foralumab. Fo...
Create a free LSE account to:
Already have an account? Sign In
Don't have an account? Register for FREE